Belgium vs United Arab Emirates: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Belgium
94.0%
in 2024
United Arab Emirates
94.0%
in 2024
Belgium rank
34th
United Arab Emirates rank
34th
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Belgium
- United Arab Emirates
How they compare
Belgium currently reports 94.0% against 94.0% in United Arab Emirates, a difference of 0.0%.
The two have swapped places 2 times across 13 shared years of data; in 2012 it was United Arab Emirates ahead.
Belgium ranks 34th and United Arab Emirates ranks 34th of 146 countries.
Across the 2 decades both report, Belgium averaged higher in 1 and United Arab Emirates in 1.
Head to head by decade
| Decade | Belgium | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 93.6% | 98.1% | 4.5% | United Arab Emirates |
| 2020s | 94.0% | 92.4% | 1.6% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Belgium or United Arab Emirates?
- Belgium, at 94.0% against 94.0% in United Arab Emirates as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Belgium and United Arab Emirates?
- 0.0%, with Belgium ahead.
- How many years of comparable data are there for Belgium and United Arab Emirates?
- 13 years are reported by both, from 2012 to 2024.
- How do Belgium and United Arab Emirates rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Belgium ranks 34th and United Arab Emirates ranks 34th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.